José A Galván Selected Research

José A Galván Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 01/2013
6	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2013
3	Inflammation (Inflammations) 01/2020 - 01/2013
2	Infections 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 07/2021 - 11/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2013
2	Carcinogenesis 01/2019 - 03/2017
2	Carcinoma (Carcinomatosis) 01/2017 - 04/2015
2	Adenocarcinoma 01/2016 - 11/2014
1	Rectal Neoplasms (Rectal Cancer) 06/2021
1	Esophageal Neoplasms (Esophageal Cancer) 05/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Kidney Neoplasms (Kidney Cancer) 11/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017
1	Hyperandrogenism 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Virilism (Virilization) 01/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2017
1	Monosomy 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 04/2015
1	Glioma (Gliomas) 04/2015
1	Keloid 04/2015
1	Lymphatic Metastasis 04/2015
1	Endotoxemia 06/2014
1	Pancreatitis 01/2013
1	Disease Progression 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Primitive Neuroectodermal Tumors (PNET) 01/2013
1	Neuroendocrine Carcinoma 01/2013
1	Celiac Disease (Celiac Sprue) 08/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 05/2014
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	VimentinIBA 01/2019 - 11/2014
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
2	Keratins (Keratin)IBA 01/2019 - 01/2019
2	EnzymesIBA 03/2017 - 01/2017
2	Dihydrotestosterone (Androstanolone)IBA 01/2017 - 01/2017
2	AndrogensIBA 01/2017 - 01/2017
2	SteroidsIBA 01/2017 - 01/2017
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Formaldehyde (Formol)FDA Link 07/2021
1	ParaffinIBA 07/2021
1	OligonucleotidesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Guanylate KinasesIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	ChromatinIBA 01/2019
1	G250 monoclonal antibodyIBA 11/2018
1	Carbonic Anhydrase IXIBA 11/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	trichostatin A (A 300)IBA 01/2018
1	theasinensin AIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Decitabine FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	LMK-235IBA 01/2018
1	Glycine Dehydrogenase (Decarboxylating)IBA 03/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016
1	TensinsIBA 01/2016
1	CollagenIBA 04/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	ProcollagenIBA 11/2014
1	DesminIBA 11/2014
1	LipopolysaccharidesIBA 06/2014
1	CDX2 Transcription FactorIBA 05/2014
1	Peptide Hydrolases (Proteases)FDA Link 11/2013
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2013
1	Everolimus FDA Link 01/2013
1	Coloring Agents (Dyes)IBA 01/2013
1	AntibodiesIBA 01/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	HLA-DQ8 antigenIBA 08/2006
1	HLA-DQ Antigens (HLA-DQ)IBA 08/2006

Therapy/Procedure

2	Neoadjuvant Therapy 06/2021 - 05/2020
2	Therapeutics 01/2019 - 01/2013
2	Lasers (Laser) 01/2016 - 01/2015
1	Adjuvant Chemotherapy 07/2021
1	Castration 01/2017